Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma

Background. The incidence of papillary thyroid carcinoma (PTC) is higher in females than in males, but it remains unclear whether gender is associated with the aggressiveness of this disease. We aimed to clarify the influence of gender on the risk of developing lymph node metastasis (LNM) and on the...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiang Zhu, Rui Huang, Ping Yu, Haoyu Ren, Xinliang Su
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2022/3534783
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556422287589376
author Jiang Zhu
Rui Huang
Ping Yu
Haoyu Ren
Xinliang Su
author_facet Jiang Zhu
Rui Huang
Ping Yu
Haoyu Ren
Xinliang Su
author_sort Jiang Zhu
collection DOAJ
description Background. The incidence of papillary thyroid carcinoma (PTC) is higher in females than in males, but it remains unclear whether gender is associated with the aggressiveness of this disease. We aimed to clarify the influence of gender on the risk of developing lymph node metastasis (LNM) and on the prognosis of PTC patients. Study Design. Retrospective cohort study. Setting. Academic tertiary care center. Methods. Clinical data of PTC patients who were admitted to the Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, between January 2013 and December 2018 were retrospectively reviewed. The differences in clinical features and outcomes between female and male patients were compared. Univariate and multivariate logistic regression analyses were conducted to assess the impact of gender on LNM. Kaplan–Meier curves were used to estimate recurrence-free survival (RFS). Results. A total of consecutive 2536 patients were enrolled in this study. Males accounted for 25.2% (639 cases) of all patients. Central lymph node metastasis (CLNM) and lateral lymph node metastasis (LLNM) rates were 52.5% (1346/2536) and 22.0% (558/2536), respectively. Male presented with higher LNM rates than female patients (65.7% vs. 51.2%; P<0.001). Male gender was independently associated with LNM (OR = 1.93, 95% CI: 1.59–2.35; P<0.001). After full adjustment, male gender still remained significantly associated with CLNM in all subgroups; however, subgroup analyses indicated no significant relationship between gender and LLNM. In addition, after a median follow-up period of 30 months, no significant difference was found in RFS between female and male patients (P=0.15). Conclusions. This observational cohort study revealed that male gender was significantly associated with CLNM; whereas, LLNM was not different between female and male PTC patients in southwestern China. Moreover, currently, there is insufficient evidence to justify that male gender is an independent prognostic factor for recurrence.
format Article
id doaj-art-0a153a2605e64f8594b8bf7f8fa308e2
institution Kabale University
issn 1687-8345
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-0a153a2605e64f8594b8bf7f8fa308e22025-02-03T05:45:28ZengWileyInternational Journal of Endocrinology1687-83452022-01-01202210.1155/2022/3534783Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid CarcinomaJiang Zhu0Rui Huang1Ping Yu2Haoyu Ren3Xinliang Su4Department of Endocrine and Breast SurgeryDepartment of AnesthesiologyDepartment of Endocrine and Breast SurgeryDepartment of Endocrine and Breast SurgeryDepartment of Endocrine and Breast SurgeryBackground. The incidence of papillary thyroid carcinoma (PTC) is higher in females than in males, but it remains unclear whether gender is associated with the aggressiveness of this disease. We aimed to clarify the influence of gender on the risk of developing lymph node metastasis (LNM) and on the prognosis of PTC patients. Study Design. Retrospective cohort study. Setting. Academic tertiary care center. Methods. Clinical data of PTC patients who were admitted to the Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, between January 2013 and December 2018 were retrospectively reviewed. The differences in clinical features and outcomes between female and male patients were compared. Univariate and multivariate logistic regression analyses were conducted to assess the impact of gender on LNM. Kaplan–Meier curves were used to estimate recurrence-free survival (RFS). Results. A total of consecutive 2536 patients were enrolled in this study. Males accounted for 25.2% (639 cases) of all patients. Central lymph node metastasis (CLNM) and lateral lymph node metastasis (LLNM) rates were 52.5% (1346/2536) and 22.0% (558/2536), respectively. Male presented with higher LNM rates than female patients (65.7% vs. 51.2%; P<0.001). Male gender was independently associated with LNM (OR = 1.93, 95% CI: 1.59–2.35; P<0.001). After full adjustment, male gender still remained significantly associated with CLNM in all subgroups; however, subgroup analyses indicated no significant relationship between gender and LLNM. In addition, after a median follow-up period of 30 months, no significant difference was found in RFS between female and male patients (P=0.15). Conclusions. This observational cohort study revealed that male gender was significantly associated with CLNM; whereas, LLNM was not different between female and male PTC patients in southwestern China. Moreover, currently, there is insufficient evidence to justify that male gender is an independent prognostic factor for recurrence.http://dx.doi.org/10.1155/2022/3534783
spellingShingle Jiang Zhu
Rui Huang
Ping Yu
Haoyu Ren
Xinliang Su
Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma
International Journal of Endocrinology
title Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma
title_full Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma
title_fullStr Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma
title_full_unstemmed Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma
title_short Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma
title_sort male gender is associated with lymph node metastasis but not with recurrence in papillary thyroid carcinoma
url http://dx.doi.org/10.1155/2022/3534783
work_keys_str_mv AT jiangzhu malegenderisassociatedwithlymphnodemetastasisbutnotwithrecurrenceinpapillarythyroidcarcinoma
AT ruihuang malegenderisassociatedwithlymphnodemetastasisbutnotwithrecurrenceinpapillarythyroidcarcinoma
AT pingyu malegenderisassociatedwithlymphnodemetastasisbutnotwithrecurrenceinpapillarythyroidcarcinoma
AT haoyuren malegenderisassociatedwithlymphnodemetastasisbutnotwithrecurrenceinpapillarythyroidcarcinoma
AT xinliangsu malegenderisassociatedwithlymphnodemetastasisbutnotwithrecurrenceinpapillarythyroidcarcinoma